Incidence of tuberculosis disease and latent tuberculosis infection in patients with end stage renal disease in an endemic region

Renal Failure

Volumn 32, Issue 1, 2010, Pages 91-95

  Ates, Gungor ^a   Yildiz, Tekin ^a   Danis, Ramazan ^b   Akyildiz, Levent ^c   Erturk, Baykal ^d   Beyazit, Huseyin ^a   Topcu, Fusun ^a  

^a DICLE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b Diyarbakir Devlet Hastanesi   (Turkey)

^c Mardin Park Hastanesi   (Turkey)

^d Diyarbakir Chest Hospital   (Turkey)

Author keywords

Hemodialysis; Latent tuberculosis; Renal disease; Tuberculin skin test; Tuberculosis

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; ENDEMIC DISEASE; EXTRAPULMONARY TUBERCULOSIS; FEMALE; HEMODIALYSIS; HUMAN; INFECTION; KIDNEY FAILURE; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; TUBERCULIN TEST; TUBERCULOSIS;

EID: 76449088151     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/08860220903367528     Document Type: Article

References (25)

1. WHO. Global tuberculosis control-surveillance, planning, financing. WHO Report 2008. Available at: http:// www.who.int/tb/publications/global-report/ 2008/download- centre/en/index.html (accessed Feb 2009).
2. Sester M, Sester U, Clauer P, et al. Tuberculin skin testing underestimates a high prevalence of latent tuberculosis infection in hemodialysis patients. Kidney Int. 2004;65: 1826-1834.
3. Hamilton CD. Infectious complications of treatment with biologic agents. Curr Opin Rheumatol. 2004;16:393-398.
4. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respire Crit Care Med. 2000;161:S221-S247.
5. Chia S, Karim M, Elwood RK, Fitzgerald JM. Risk of tuberculosis in dialysis patients: A population-based study. Int J Tuberc Lung Dis. 1998;2:989-991.
6. Andrew OT, Schoenfeld PY, Hopewell PC, and Humphreys MH. Tuberculosis in patients with end-stage renal disease. Am J Med. 1980;68:59-65.
7. Hussein MM, Mooij JM, and Roujouleh H. Tuberculosis and chronic renal disease. Semin Dial. 2003;16:38.
8. Wauters A, Peetermans WE, Van den Brande P, et al. The value of tuberculin skin testing in hemodialysis patients. Nephrol Dial Transplant. 2004;19:433-438.
9. Rutsky EA, Rostand SG. Mycobacteriosis in patients with chronic renal failure. Arch Intern Med. 1980;140:57-61.
10. Korzets A, Gafter U. Tuberculosis prophylaxis for the chronically dialysed patient-yes or no? Nephrol Dial Transplant. 1999;14:2857-2859.
11. Hussein M, Mooij J. Tuberculosis and chronic renal disease. Saudi J Kidney Dis Transpl. 2002;13:320-330.
12. Erkoc R, Dogan E, Sayarlioglu H, et al. Tuberculosis in dialysis patients, single centre experience from an endemic area. Int J Clin Pract. 2004;58(12):1115-1117.
13. Smirnoff M, Patt C, Seckler B, Adler JJ. Tuberculin and anergy skin testing of patients receiving long-term hemodialysis. Chest. 1998;113:25-27.
14. Menzies D, Pai M, Comstock G. Meta-analysis: New tests for the diagnosis of latent tuberculosis infection: Areas of uncertainty and recommendations for research. Ann Intern Med. 2007;146:340-354.
15. Ates G, Ozekinci T, Yildiz T, Danis R. Comparison of interferon-gamma release assay versus tuberculin skin test for latent tuberculosis screening in hemodialysis patients. Biotechnol Equip. 2009;23:1242-1246.
16. Pradhan RP, Katz LA, Nidus BD, Matalon R, Eisinger RP. Tuberculosis in dialyzed patients. JAMA. 1974;229: 798-800.
17. Rutkowski B, Sulima-Gillow A, Kustosz J, Liberek T, Zdrojewski Z. Increasing incidence of tuberculosis in hemodialysis patients. Dial Transplant. 1997;26:21-23.
18. Cengiz K. Increased incidence of tuberculosis in patients undergoing hemodialysis. Nephron. 1996;73:421-424.
19. Taskapan H, Utas C, Oymak FS, Gulmez I, Ozesmi M. The outcome of tuberculosis in patients on chronic hemodialysis. Clin Nephrol. 2000;54:134-137. (Pubitemid 30625631)
20. Sen N, Turunc T, Karatasli M, Sezer S, Demiroglu YZ, Oner-Eyuboglu F. Tuberculosis in patients with end-stage renal disease undergoing dialysis in an endemic region of Turkey. Transplant Proc. 2008;40:81-84.
21. Kayabasi H, Sit D, Kadiroglu AK, Kara IH, Yilmaz ME. The prevalence and the characteristics of tuberculosis patients undergoing chronic dialysis treatment: Experience of a dialysis center in southeast Turkey. Ren Fail. 2008;30:513-519.
22. Bozkurt H, Türkkani MH, Musaonbasioglu S, et al. Türkiye'de Verem Savasi, 2009 Raporu. Verem Savasi Dairesi Baskanligi. Ankara, Turkey; 2009.
23. Ozdemir FN, Guz G, Kayatas M, Sezer S, Turan M. Tuberculosis remains an important factor in the morbidity and mortality of hemodialysis patients. Transplant Proc. 1998;30:846-847.
24. Machiraju S, Shankar R, Aravindan AN, Sohal PM, Kohli HS, Sud K, Gupta KL, Sakhuja V, Jha V. The prevalence of tuberculin sensitivity and anergy in chronic renal failure in an endemic area: Tuberculin test and the risk of posttransplant tuberculosis. Nephrol Dial Transplant. 2005;20: 2720-2724.
25. Woeltje KF, Mathew A, Rothstein M. Tuberculosis infection and anergy in hemodialysis patients. Am J Kidney Dis. 1998;31:848-852.